论文部分内容阅读
目的对比分析维吾尔族和汉族多发性骨髓瘤(Multiple Myeloma,MM)骨转移患者应用89Srcl2的疗效。方法用89Srcl2治疗44例维吾尔族和63例汉族MM骨转移骨痛患者后,观察其镇痛效果、C反应蛋白(CRP)、乳酸脱氢酶(LDH)和白细胞介素-6(IL-6)的变化。结果89Srcl2治疗后,汉族MM骨转移患者与维吾尔族患者相比镇痛效率较高且CRP、LDH和IL-6水平降低明显,差异均有统计学意义(P﹤0.05)。结论用89Srcl2治疗MM骨转移患者骨痛时,汉族患者较维吾尔族患者疗效更好。
Objective To compare the efficacy of 89Srcl2 in patients with multiple myeloma (MM) bone metastasis in Uighur and Han Chinese. Methods 89Srcl2 treatment of 44 Uighurs and 63 Han bone metastases of bone pain patients were observed the analgesic effect, C-reactive protein (CRP), lactate dehydrogenase (LDH) and interleukin-6 (IL-6 )The change. Results After 89Srcl2 treatment, the patients with MM bone metastasis in Han nationality had higher analgesic efficiency and lower CRP, LDH and IL-6 levels than those in Uygur patients (P <0.05). Conclusion 89Srcl2 treatment of bone metastases in patients with bone pain, Han patients than Uighur patients better.